What we do

isoSolutions Marketing & Management Inc. offers a wide range of products for nuclear medicine applications, from a variety of reliable suppliers, providing a one-stop shopping service as well as technical support.


David T. Drummond Managing Director

People matter the most. Every organization should aim to leave people better off. In the health sector that starts with the patient but must also include our suppliers, customers, employees, partners — indeed, everyone whose life is touched by our company.


Companies connected
through isoSolutions


Orders delivered
worldwide in 2017


Orders delivered
on time in 2017


First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Kevin Yang ⎜ Sep 12, 2018

This first-in-human study demonstrated that 177Lu-EB-PSMA-617 had higher accumulation in mCRPC and that low
imaging dose appears to be effective in treating tumors with high 68Ga-PSMA-617 uptakes. Elevated uptakes of 177Lu-EBPSMA-617 in kidneys and red bone marrow were well tolerated at the administered low dose. Further investigations with increased dose and frequency of administration are warranted.

Jie Zang & Xinrong Fan & Hao Wang & Qingxing Liu & Jingnan Wang & Hui Li & Fang Li & Orit Jacobson & Gang Niu & Zhaohui Zhu & Xiaoyuan Chen

Read the full article

Info on purchasing Lu-177, please contact sales@isosolutions.com.

keep reading

Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors

Kevin Yang ⎜ Sep 6, 2018

Prostate cancer is the most frequently diagnosed malignant tumor in men worldwide. Prostate-specific membrane antigen (PSMA) is a surface molecule specifically expressed by prostate tumors and has been shown to be a valid target for internal radionuclide therapy in both preclinical and clinical settings. The most common radiotherapeutic agent is the small molecule 177Lu-PSMA-617,

keep reading


Sep 12 to 15

United Pharmacy Partners (UPPI, LLC) 2018 Annual Meeting

isoSolutions will be attending the United Pharmacy Partners (UPPI, LLC) 2018 Annual Meeting to be held in San Antonio, TX September 12 to 15, 2018.

Jul 12 to 15

Chinese Society of Nuclear Medicine Annual Meeting 2018

The Chinese Society of Nuclear Medicine Annual Meeting will be held in Chengdu, Sichuan from 2018–07–12 to 2018–07–15. We hope to see you there and we can arrange a time and place to meet if you wish.

Jun 23 to 26

Society of Nuclear Medicine and Molecular Imaging Annual Meeting 2018

Pennsylvania Convention Center, Headquarter Hotel: Philadelphia Marriott. isoSolutions is pleased to inform you that we will attend the Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)